Incucyte S3: Comprehensive cellular phenotyping using high-throughput live cell imaging

15 December 2022 → 14 December 2024
Regional and community funding: Special Research Fund
Research disciplines
  • Medical and health sciences
    • Cardiology
    • Immunogenetics
    • Cell growth and development
    • Developmental biology
    • Epigenetics
    • Genetics
    • Stem cell biology
    • Neurological and neuromuscular diseases
    • Cancer diagnosis
    • Cell growth and development
    • Cancer therapy
    • Opthalmology not elsewhere classified
microscopy tissue culture proliferation and viability of cells Life cell imaging
Project description

The new Incucyte S3 will allow in vitro high-throughput functional analysis under normal and genetically or pharmacologically perturbation conditions in the field of cancer genetics as well as rare diseases. This device is highly needed to meet the increasing demand of the existing Incucyte platform by both existing and new users. In addition, it will enable us to implement new applications such as organoid cultures to accelerate multiple ongoing research projects.